Undifferentiated Pleomorphic Sarcoma
1 competing product in clinical development for Undifferentiated Pleomorphic Sarcoma.
Pipeline by Phase
Phase 1/21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| CAB-AXL-ADC + PD-1 inhibitor | BioAtla | Phase 1/2 | Completed | 33 |